Task: Answer Verification
Input (English): Question: Are pharmacokinetics and pharmacodynamics of the antiplatelet combination aspirin ( acetylsalicylic acid ) plus extended-release dipyridamole altered by coadministration with the potent CYP2C19 inhibitor omeprazole?
Answer: The PK and PD behavior of ASA + ER-DP was not altered by concurrent administration of omeprazole.
Output (English): no